TAZI
LIVE

Serial Number

79415523

Owner

GlydeIt IP Pty Ltd

Attorney

James C. Watson

Filing Date

Dec 17, 2024

Add to watchlist:

No watchlists yet
View on USPTO

TAZI Trademark

Serial Number: 79415523 • Registration: 7954212

TAZI is a trademark filed by GlydeIt IP Pty Ltd on December 17, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

GlydeIt IP Pty Ltd

60 Blake St

Entity Type: 82

Trademark Details

Filing Date

December 17, 2024

Registration Date

September 23, 2025

Published for Opposition

August 5, 2025

Goods & Services

Menstruation tampons; sanitary tampons; sanitary napkins; sanitary pants

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 29, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 29, 2026 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 23, 2026 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Apr 3, 2026 FICS
FINAL DISPOSITION PROCESSED
Apr 2, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 23, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 23, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 23, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 5, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 5, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 30, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 13, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 13, 2025 TROA
REFUSAL PROCESSED BY IB
May 24, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 3, 2025 RFCS
REFUSAL PROCESSED BY MPU
May 3, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 19, 2025 RFCR
NON-FINAL ACTION WRITTEN
Mar 18, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 17, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 3, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 3, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 30, 2025 REPR